跳至主要内容
临床试验/NL-OMON42670
NL-OMON42670尚未招募不适用

Evaluation of a high-resolution dedicated hanging breast PET guided biopsy device for breast cancer diagnosis. - MAMMOCARE

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Age >18 years
  • -Patients who are referred to the AVL for neo-adjuvant chemotherapy treatment
  • -Histological confirmed breast cancer (stage II/III)
  • -Breast tumour >= 2cm

排除标准

  • - 18F-FDG non-avid primary tumour (SUVmax < 2.5) on conventional hanging breast PET/CT
  • - Breast tumour SUVmax lower than two times the SUVmax of surrounding normal breast tissue on conventional hanging breast PET/CT
  • - Primary tumours located within 2.5 cm distance from the chest wall (selection based on earlier performed mammography, hanging breast MRI or PET/CT).
  • - Active infection (breast or systemic) requiring antibiotics.
  • - Breast implant in affected breast
  • - Blood sugar level more than 10 mg/ml at time of 18F-FDG injection
  • - Anticoagulants usage with International Normalized Ratio (INR) > 2 on the day of biopsy
  • - Pregnancy

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验